TOKYO -- Japan's pharmaceutical regulatory authority will open its first overseas office in Bangkok as early as 2024, aiming for it to become an entry point for Japanese pharmaceutical companies into fast-growing Southeast Asian markets.
Tokyo aims for more of its drugs to enter Asian markets, but experts skeptical

Japan's Pharmaceuticals and Medical Devices Agency plans to facilitate more communication with its counterparts through opening a new office in Bangkok.
TOKYO -- Japan's pharmaceutical regulatory authority will open its first overseas office in Bangkok as early as 2024, aiming for it to become an entry point for Japanese pharmaceutical companies into fast-growing Southeast Asian markets.